Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-033481
Filing Date
2025-04-10
Accepted
2025-04-10 06:00:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7455
  Complete submission text file 0001104659-25-033481.txt   9519
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filed by) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Subject) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93313 | Film No.: 25826353
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)